Home603193 • SHA
add
Runben Biotechnology Co Ltd
Nakaraang pagsara
¥38.64
Sakop ng araw
¥37.30 - ¥39.88
Sakop ng taon
¥15.80 - ¥39.88
Market cap
15.63B CNY
Average na Volume
3.75M
P/E ratio
49.05
Dividend yield
0.71%
Primary exchange
SHA
Mga balita tungkol sa merkado
Barron's
19 minuto ang nakalipas
S&P 500 Futures Rise in Premarket Trading; McCormick Vtg, Glaukos Lag
0.15%
0.53%
Investor's Business Daily
6 oras ang nakalipas
Two Titans Lift Futures; Tesla Eyed Replacing Elon Musk
0.98%
0.31%
0.35%
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 240.03M | 44.00% |
Gastos sa pagpapatakbo | 93.73M | 42.76% |
Net na kita | 44.20M | 24.60% |
Net profit margin | 18.41 | -13.49% |
Kita sa bawat share | — | — |
EBITDA | 49.66M | 54.80% |
Aktuwal na % ng binabayarang buwis | 12.31% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.39B | 947.09% |
Kabuuang asset | 2.30B | 11.45% |
Kabuuang sagutin | 176.92M | 63.50% |
Kabuuang equity | 2.12B | — |
Natitirang share | 401.79M | — |
Presyo para makapag-book | 7.30 | — |
Return on assets | 4.94% | — |
Return on capital | 5.31% | — |
Cash Flow
Net change in cash
| (CNY) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 44.20M | 24.60% |
Cash mula sa mga operasyon | -15.00M | 47.03% |
Cash mula sa pag-invest | -28.83M | 80.83% |
Cash mula sa financing | -379.77K | 0.00% |
Net change in cash | -44.21M | 75.31% |
Malayang cash flow | 12.61M | 100.85% |
Tungkol
Itinatag
Dis 30, 2013
Website
Mga Empleyado
917
